J. Blankson

J. Blankson, S. Forman, R. Ambinder, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.

J. Blankson, Bezawit A. Woldemeskel, Caroline C. Garliss, 2021, The Journal of clinical investigation.

Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses.

Shibin Zhou, J. Blankson, D. Pardoll, 2021, The Journal of clinical investigation.

Natural control of HIV infection in young women in South Africa: HPTN 068

J. Blankson, J. Hughes, F. Gómez-Olivé, 2018, HIV clinical trials.

A Human Immunodeficiency Virus Controller With a Large Population of CD4+CD8+ Double-Positive T Cells

J. Blankson, R. Ambinder, C. Durand, 2015, Open forum infectious diseases.

Candida Esophagitis in a Human Immunodeficiency Virus-1-Positive Elite Controller With Hepatitis C Virus Cirrhosis

J. Blankson, Eugenie C Shieh, S. Brinkley, 2014, Open forum infectious diseases.

Higher Proinflammatory Cytokines Are Associated With Increased Antibody Titer After a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients

J. Blankson, S. Klein, D. Segev, 2022, Transplantation.

Preservation of FoxP3 (cid:1) Regulatory T Cells in the Peripheral Blood of Human Immunodeﬁciency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4 (cid:1) T-Cell Activation (cid:1)

R. Siliciano, J. Blankson, Hung‐Chih Yang, 2008 .

Crosscurrents in HIV-1 evolution

R. Siliciano, J. Blankson, J. Bailey, 2006, Nature Immunology.

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4 (cid:2) T Cells to HIV-1-Speciﬁc CD8 (cid:2) T Cells

J. Blankson, P. Tarwater, Valerie J Cohen, 2015 .

Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient

J. Blankson, A. Karaba, Bezawit A. Woldemeskel, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Spontaneous resolution of HIV-associated nephropathy in an elite controller.

D. Fine, J. Blankson, M. Kuperman, 2011, AIDS.

Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro

R. Siliciano, J. Blankson, G. Laird, 2015, AIDS.

Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors

J. Blankson, C. Thio, M. Sulkowski, 2011, AIDS.

Potential limitation of CCR5 antagonists: drug resistance more often linked to CXCR4-utilizing than to CCR5-utilizing HIV-1

J. Blankson, J. Stapleton, G. Kirk, 2008, AIDS.

The CD28/B7 pathway costimulates the response of primary murine T cells to superantigens as well as to conventional antigens.

S. Morse, J. Blankson, 1994, Cellular immunology.

SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection

T. Westlake, J. Blankson, D. Pardoll, 2022, eBioMedicine.

SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations

J. Blankson, A. Marchant, A. Tobian, 2022, medRxiv.

Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

A. Casadevall, S. Cramer, O. Laeyendecker, 2022, JCI insight.

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response

J. Blankson, S. Klein, D. Segev, 2022, Transplantation.

Murine monoclonal antibodies specific for conserved and non-conserved antigenic determinants of the human and murine Ku autoantigens

J. Blankson, D. Pisetsky, M. Knuth, 1993, Molecular Biology Reports.

Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2.

O. Laeyendecker, J. Blankson, S. Ray, 2020, The Journal of clinical investigation.

A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency

J. Blankson, Abena K. Kwaa, Caroline C. Garliss, 2020, Open forum infectious diseases.

The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs

J. Blankson, Kelly A. Metcalf Pate, 2017, Retrovirology.

Weak HIV Antibody Responses in Perinatally Infected Young Adults: Weak HIV Antibody Responses in Perinatally Infected Adults

Richard D Moore, O. Laeyendecker, J. Blankson, 2017, The Pediatric infectious disease journal.

Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy.

J. Blankson, A. Spivak, R. Ambinder, 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs

J. Blankson, Kelly A. Metcalf Pate, 2017, Retrovirology.

A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads.

J. Clements, J. Blankson, M. Zink, 2015, The Journal of infectious diseases.

An Atypical Case of Fatal Zygomycosis: Simultaneous Cutaneous and Laryngeal Infection in a Patient with a Non-neutropenic Solid Prostatic Tumor

J. Blankson, W. Merz, B. Goldstein, 2008, Ear, nose, & throat journal.

Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.

Brigitte E. Sanders-Beer, F. Kashanchi, J. Burnett, 2016, AIDS research and human retroviruses.

Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure

Sarah B. Laskey, Robert F. Siliciano, Daniel I. S. Rosenbloom, 2013, Cell.

Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

R. Siliciano, J. Blankson, J. Siliciano, 2006, Journal of Virology.

Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients

J. Clements, J. Blankson, K. Witwer, 2012, Retrovirology.

A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses

R. Siliciano, F. Bushman, J. Margolick, 2019, Nature.

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

R. Siliciano, D. Richman, D. Kuritzkes, 2017, PLoS medicine.

Latent reservoirs for HIV-1.

R. Siliciano, J. Blankson, D. Persaud, 1999, Current opinion in infectious diseases.

Preservation of FoxP3+ Regulatory T Cells in the Peripheral Blood of Human Immunodeficiency Virus Type 1-Infected Elite Suppressors Correlates with Low CD4+ T-Cell Activation

R. Siliciano, J. Blankson, Hung‐Chih Yang, 2008, Journal of Virology.

Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutations

Robert F. Siliciano, Thomas M. Williams, R. Siliciano, 2006, The Journal of experimental medicine.

HLA-B*57 Elite Suppressor and Chronic Progressor HIV-1 Isolates Replicate Vigorously and Cause CD4+ T Cell Depletion in Humanized BLT Mice

R. Siliciano, M. Swanson, J. Blankson, 2014, Journal of Virology.

CD8+ T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants

R. Siliciano, J. Blankson, C. Pohlmeyer, 2013, Retrovirology.

Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells

R. Siliciano, J. Blankson, R. Buckheit, 2013, Retrovirology.

The implications of viral reservoirs on the elite control of HIV-1 infection

J. Blankson, M. Salgado, Karen Martins, 2013, Cellular and Molecular Life Sciences.

Inhibitory Potential of Subpopulations of CD8+ T Cells in HIV-1-Infected Elite Suppressors

J. Blankson, R. Buckheit, M. Salgado, 2012, Journal of Virology.

Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs

R. Siliciano, J. Blankson, J. Gallant, 2012, Nature Communications.

Residual Viremia and Viral Reservoirs in Elite Controllers

J. Blankson, R. Buckheit, 2012 .

Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapy

R. Siliciano, J. Margolick, J. Blankson, 2011, Retrovirology.

Viral suppression of multiple escape mutants by de novo CD8+ T cell responses in a human immunodeficiency virus-1 Infected elite suppressor

R. Siliciano, J. Blankson, Robert W. Hegarty, 2011, Retrovirology.

The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?

J. Blankson, 2011, Current opinion in HIV and AIDS.

Evolution of the HIV-1 nef gene in HLA-B*57 Positive Elite Suppressors

R. Siliciano, J. Blankson, S. Ray, 2010, Retrovirology.

Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus

R. Siliciano, J. Blankson, S. Ray, 2010, Journal of Virology.

Effector mechanisms in HIV-1 infected elite controllers: highly active immune responses?

J. Blankson, 2010, Antiviral research.

Elucidating the elite: mechanisms of control in HIV-1 infection.

J. Blankson, J. Bailey, Karen A. O’Connell, 2009, Trends in pharmacological sciences.

Evidence of CD8+ T-Cell-Mediated Selective Pressure on Human Immunodeficiency Virus Type 1 nef in HLA-B*57+ Elite Suppressors

R. Siliciano, J. Blankson, J. Bailey, 2008, Journal of Virology.

Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite Suppressor

R. Siliciano, J. Blankson, S. Ray, 2008, Journal of Virology.

Developing strategies for HIV-1 eradication.

R. Siliciano, J. Blankson, C. Durand, 2012, Trends in immunology.

Interleukin 2 treatment for HIV infection.

R. Siliciano, J. Blankson, 2000, JAMA.

Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals

R. El-Diwany, J. Blankson, S. Ray, 2017, AIDS.

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike

Carly A. Bobak, J. Weiner, J. Blankson, 2021, medRxiv.

Viral reservoirs and HIV-specific immunity

J. Blankson, 2006, Current opinion in HIV and AIDS.

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.

R. Siliciano, J. Blankson, J. Bailey, 2004, Current opinion in immunology.

HIV Antibody Profiles in HIV Controllers and Persons With Treatment-Induced Viral Suppression

Richard D Moore, I. Ruczinski, C. Morrison, 2021, Frontiers in Immunology.

Highly Attenuated Infection With a Vpr-Deleted Molecular Clone of Human Immunodeficiency Virus-1

D. Burton, O. Yang, Ayub Ali, 2018, The Journal of infectious diseases.

Understanding the CD 8 T-cell response in natural HIV control

J. Blankson, 2019 .

Prolonged control of an HIV type 1 escape variant following treatment interruption in an HLA-B*27-positive patient.

J. Blankson, T. Williams, R. Pelz, 2010, AIDS research and human retroviruses.

HIV-1 Gag evolution in recently infected human leukocyte antigen-B*57 patients with low-level viremia

J. Margolick, J. Blankson, T. Williams, 2010, AIDS.

Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+T cells

R. Siliciano, J. Blankson, R. Buckheit, 2013, Retrovirology.

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

R. Siliciano, J. Margolick, J. Blankson, 2012, Immunity.

CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors

R. Siliciano, J. Blankson, S. A. Rabi, 2011, Proceedings of the National Academy of Sciences.

Circulating Monocytes Are Not a Major Reservoir of HIV-1 in Elite Suppressors

J. Blankson, A. Spivak, S. A. Rabi, 2011, Journal of Virology.

Unstimulated Primary CD4+ T Cells from HIV-1-Positive Elite Suppressors Are Fully Susceptible to HIV-1 Entry and Productive Infection

R. Siliciano, J. Blankson, D. Nikolaeva, 2010, Journal of Virology.

A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy.

R. Siliciano, J. Blankson, J. Dinoso, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors

R. Siliciano, J. Blankson, J. Gallant, 2008, AIDS.

Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape.

R. Siliciano, J. Blankson, Hung‐Chih Yang, 2007, The Journal of infectious diseases.

Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy

Thomas C. Quinn, Robert F. Siliciano, Stuart C. Ray, 2006, Journal of Virology.

The implications of viral reservoirs on the elite control of HIV-1 infection

J. Blankson, M. Salgado, Karen Martins, 2012, Cellular and Molecular Life Sciences.

T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors.

C. Wilke, J. Blankson, A. Sedaghat, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD8+T cells from HLA-B*57 elite suppressors effectively suppress replication of HIV-1 escape mutants

R. Siliciano, J. Blankson, C. Pohlmeyer, 2013, Retrovirology.

Finding a cure for human immunodeficiency virus-1 infection.

R. Siliciano, J. Blankson, J. Siliciano, 2014, Infectious disease clinics of North America.

MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy.

R. Siliciano, J. Blankson, 2001, The Journal of clinical investigation.

HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon

J. Blankson, D. Pardoll, M. Chattergoon, 2014, PLoS pathogens.

Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses

Richard D Moore, R. Siliciano, J. Blankson, 2018, PloS one.

Rapid Quantification of the Latent Reservoir for HIV-1 Using a Viral Outgrowth Assay

R. Siliciano, J. Blankson, J. Siliciano, 2013, PLoS pathogens.

Combined Effects of HLA-B*57/5801 Elite Suppressor CD8+ T Cells and NK Cells on HIV-1 Replication

Madeleine C. Mankowski, J. Blankson, J. Bailey, 2020, Frontiers in Cellular and Infection Microbiology.

A Simian Immunodeficiency Virus-Infected Macaque Model To Study Viral Reservoirs That Persist during Highly Active Antiretroviral Therapy

R. Siliciano, J. Clements, J. Blankson, 2009, Journal of Virology.

The Effect of Latency Reversal Agents on Primary CD8 + T Cells: Implications for Shock and Kill Strategies for Human Immunodeficiency Virus Eradication

J. Blankson, P. Tarwater, C. Pohlmeyer, 2016, EBioMedicine.

The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir.

J. Blankson, R. Veenhuis, 2017, Current topics in microbiology and immunology.

Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller

M. Carrington, O. Laeyendecker, J. Blankson, 2017, EBioMedicine.

Role of Natural Killer Cells in a Cohort of Elite Suppressors: Low Frequency of the Protective KIR3DS1 Allele and Limited Inhibition of Human Immunodeficiency Virus Type 1 Replication In Vitro

Robert F. Siliciano, Thomas M. Williams, R. Siliciano, 2009, Journal of Virology.

Elite suppression of HIV-1 replication.

R. Siliciano, J. Blankson, 2008, Immunity.

HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation

J. Blankson, A. Tsibris, G. Kirk, 2016, PloS one.

Effective Downregulation of HLA-A*2 and HLA-B*57 by Primary Human Immunodeficiency Virus Type 1 Isolates Cultured from Elite Suppressors

J. Blankson, Yan Zhou, Eric Nou, 2009, Journal of Virology.

People with HIV-1 Demonstrate Type 1 Interferon Refractoriness Associated with Upregulated USP18

R. El-Diwany, J. Blankson, S. Mehta, 2021, Journal of Virology.

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021

J. Nabukenya, T. Ndung’u, S. Lewin, 2021, Nature Medicine.

Elite Controllers are Hospitalized More Often than Persons with Medically Controlled HIV

Richard D Moore, J. Blankson, P. Korthuis, 2014 .

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells

J. Blankson, P. Tarwater, Valerie J Cohen, 2015, Journal of Virology.

Immunology of Latent HIV Infection

J. Blankson, R. Buckheit, 2014 .

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.

R. Siliciano, J. Margolick, T. Pierson, 2000, The Journal of infectious diseases.

Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1

Robert F. Siliciano, Janet D. Siliciano, R. Siliciano, 2000, Journal of Virology.

Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA

R. Siliciano, L. Montaner, J. Blankson, 2020, Proceedings of the National Academy of Sciences.

A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses

R. Siliciano, F. Bushman, J. Margolick, 2019, Nature.

Does B Cell Follicle Exclusion of CD8+ T Cells Make Lymph Nodes Sanctuaries of HIV Replication?

J. Blankson, R. Veenhuis, S. Beck, 2019, Front. Immunol..

Sprouty-2 regulates HIV-specific T cell polyfunctionality.

H. Zhang, J. Margolick, J. Blankson, 2014, Journal of Clinical Investigation.

Prolonged viral suppression without therapy in an HIV-1 seroconverter following early antiretroviral therapy and daily interleukin-2.

J. Margolick, J. Blankson, J. Gallant, 2010, AIDS.

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

J. Blankson, S. Klein, D. Segev, 2021, American Journal of Transplantation.

Evaluation of Parvovirus B19 Infection in Children with Malignant or Hematological Disorders

C. Wilke, J. Blankson, A. Sedaghat, 2010 .

Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors

Robert F. Siliciano, Janet D. Siliciano, R. Siliciano, 2007, Journal of Virology.

SARS-CoV-2–specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge

O. Laeyendecker, J. Blankson, A. Yang, 2022, JCI insight.

Challenges in optimizing preexposure prophylaxis development, engagement, and access for HIV prevention.

J. Blankson, E. Scully, E. Weld, 2019, The Journal of clinical investigation.

Failure to Identify HIV-Infected Individuals in a Clinical Trial Using a Single HIV Rapid Test for Screening

Richard D Moore, O. Laeyendecker, J. Blankson, 2014, HIV clinical trials.

The Esperanza Patient: More Hope for a Sterilizing HIV-1 Cure

J. Blankson, 2021, Annals of Internal Medicine.

Effect of Natural and ARV-Induced Viral Suppression and Viral Breakthrough on Anti-HIV Antibody Proportion and Avidity in Patients with HIV-1 Subtype B Infection

Richard D Moore, R. Brookmeyer, O. Laeyendecker, 2013, PloS one.

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Shedding in a Patient With AIDS: Case Report and Review of the Literature

J. Blankson, A. Tobian, H. Mostafa, 2022, Open forum infectious diseases.

Comparative Analysis of the Capacity of Elite Suppressor CD4+ and CD8+ T Cells To Inhibit HIV-1 Replication in Monocyte-Derived Macrophages

J. Blankson, R. Buckheit, Victoria E Walker-Sperling, 2014, Journal of Virology.

Monocyte-Derived Macrophages To Inhibit HIV-1 Replication in T Cells + and CD 8 + Elite Suppressor CD 4 Comparative Analysis of the Capacity of

J. Blankson, R. Buckheit, Victoria E Walker-Sperling, 2014 .

Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.

O. Laeyendecker, J. Blankson, A. Karaba, 2022, AIDS.

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)

O. Laeyendecker, J. Blankson, A. Karaba, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bivalent mRNA vaccine-elicited SARS-CoV-2 specific T cells recognise the omicron XBB sublineage

J. Blankson, Caroline C Traut, 2023, The Lancet Microbe.

A third dose of SARS-CoV-2 vaccine increases neutralizing antibodies against variants of concern in solid organ transplant recipients

J. Blankson, S. Klein, D. Segev, 2021, American Journal of Transplantation.

mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.

J. Blankson, Bezawit A. Woldemeskel, Caroline C. Garliss, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants

J. Blankson, Jiajia Zhang, Kellie N. Smith, 2020, Frontiers in Immunology.

Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities.

A. Adimora, J. Blankson, J. Marrazzo, 2017, The Journal of infectious diseases.

Monocyte-derived macrophages contain persistent latent HIV reservoirs

J. Clements, J. Blankson, L. Rubin, 2023, Nature Microbiology.

Control of HIV-1 replication in elite suppressors.

J. Blankson, Joel N Blankson, 2010, Discovery medicine.

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

F. Bushman, J. Blankson, E. Scully, 2018, JCI insight.

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection

J. Blankson, J. Bailey, R. Veenhuis, 2021, Frontiers in Immunology.

Elite suppressors have low frequencies of intact HIV-1 proviral DNA.

J. Blankson, G. Laird, Caroline C. Garliss, 2019, AIDS.

Characterization of Elite Suppressors Cell-Associated HIV-1 mRNA at Baseline and with T Cell Activation  

J. Blankson, G. Laird, Alyssa R. Martin, 2017, The Yale journal of biology and medicine.

What can we do to reduce the viral reservoir in HIV-1-infected individuals?

J. Blankson, C. Pohlmeyer, Victoria E Walker-Sperling, 2016, Future microbiology.

Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department

O. Laeyendecker, S. Truelove, J. Blankson, 2022, Journal of clinical microbiology.

Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department

O. Laeyendecker, S. Truelove, J. Blankson, 2021, medRxiv.

How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.

J. Blankson, Jonathan Z. Li, 2021, The Journal of clinical investigation.

Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.

Richard D Moore, J. Margolick, O. Laeyendecker, 2016, AIDS research and human retroviruses.

The effect of Ingenol-B on the suppressive capacity of elite suppressor HIV-specific CD8+ T cells

J. Blankson, L. Gama, L. Pianowski, 2017, PloS one.

Seronegative HIV-1 infection: a review of the literature

J. Blankson, J. Gallant, A. Spivak, 2010, AIDS.

Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients

J. Clements, J. Blankson, K. Witwer, 2012, Retrovirology.

Primary HIV-1 infection: to treat or not to treat?

J. Blankson, 2005, The AIDS reader.

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike

Carly A. Bobak, J. Weiner, J. Blankson, 2022, eLife.

Evolution of an attenuated HIV-1 isolate in an elite suppressor.

J. Blankson, G. Berkenblit, R. Buckheit, 2014, AIDS research and human retroviruses.

Heterologous versus homologous boosting elicits qualitatively distinct, BA.5–cross-reactive T cells in transplant recipients

J. Blankson, D. Segev, N. Rouphael, 2023, JCI insight.

CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses

J. Blankson, Kellie N. Smith, Bezawit A. Woldemeskel, 2022, The Journal of clinical investigation.

Killing the messenger to maintain control of HIV

J. Blankson, 2011, Nature Medicine.

HIV type 1-mediated downregulation of HLA-B*57/B*5801 proteins on elite suppressor CD4+ T cells.

J. Blankson, C. Ceccato, M. Sampah, 2011, AIDS research and human retroviruses.

Unstimulated Primary CD4 (cid:1) T Cells from HIV-1-Positive Elite Suppressors Are Fully Susceptible to HIV-1 Entry and Productive Infection (cid:1)

R. Siliciano, J. Blankson, Lin Shen, 2010 .

Reply to Torre

C. Wilke, J. Blankson, A. Sedaghat, 2010 .

Subclinical cardiovascular disease in HIV controller and long‐term nonprogressor populations

M. Budoff, K. Anastos, L. Kingsley, 2019, HIV medicine.

A tribute to John G. Bartlett, MD (1937-2021).

J. Blankson, T. Quinn, 2021, The Journal of clinical investigation.

Optimization and Evaluation of an in Vitro Yeast Assay to Predict Phototoxicity

J. Blankson, D. Bagley, B. Kong, 1988 .

393 – Immunopathogenesis of Human Immunodeficiency Virus Infection

R. Siliciano, J. Blankson, 2011 .

HIV-antibody complexes enhance production of type I interferon by plasmacytoid dendritic cells

J. Margolick, J. Blankson, M. Ackerman, 2017, The Journal of clinical investigation.

SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

J. Blankson, A. Marchant, A. Tobian, 2023, Nature communications.

Replacing cART with CAR-T Cells: Using Immunotherapy to Cure HIV.

J. Blankson, S. Beck, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients

J. Blankson, D. Segev, Y. Eby, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.

J. Blankson, D. Segev, D. Warren, 2022, Transplantation.

Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite Controller

J. Blankson, S. Grossman, K. Reiss, 2016, Open forum infectious diseases.

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.

R. Siliciano, J. Blankson, J. Gallant, 2001, The Journal of infectious diseases.

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

R. Siliciano, J. Margolick, J. Blankson, 2012, Immunity.

Proviral location affects cognate peptide–induced virus production and immune recognition of HIV-1–infected T cell clones

F. Bushman, J. Blankson, R. Veenhuis, 2023, Journal of Clinical Investigation.

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells

J. Blankson, P. Tarwater, Valerie J Cohen, 2015, Journal of Virology.

Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities.

A. Adimora, J. Blankson, J. Marrazzo, 2017, The Journal of infectious diseases.

Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary.

Brigitte E. Sanders-Beer, F. Kashanchi, J. Burnett, 2016, AIDS research and human retroviruses.

T cell dynamics and the response to HAART in a cohort of HIV-1-infected elite suppressors.

C. Wilke, J. Blankson, A. Sedaghat, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load

I. Ruczinski, O. Laeyendecker, J. Blankson, 2023, Frontiers in immunology.

The study of elite controllers: a pure academic exercise or a potential pathway to an HIV-1 vaccine?

J. Blankson, 2011, Current opinion in HIV and AIDS.

Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.

J. Blankson, C. Merlo, G. Kirk, 2016, AIDS research and human retroviruses.

Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.

F. Bushman, J. Blankson, E. Scully, 2018, JCI insight.

A Human Immunodeficiency Virus Controller With a Large Population

J. Blankson, R. Ambinder, C. Durand, 2015 .

Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus

R. Siliciano, J. Blankson, S. Ray, 2010, Journal of Virology.

Evidence of CD8+ T-Cell-Mediated Selective Pressure on Human Immunodeficiency Virus Type 1 nef in HLA-B*57+ Elite Suppressors

R. Siliciano, J. Blankson, J. Bailey, 2008, Journal of Virology.

Three doses of COVID-19 mRNA vaccine induce class-switched antibody responses in inflammatory arthritis patients on immunomodulatory therapies

Venkata Gayatri Dhara, J. Blankson, A. Pekosz, 2023, Frontiers in immunology.